ALLMedicine™ Diplopia Center

Dec 3rd, 2021 - Background: Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care ...

Nov 27th, 2021 - Visual complaints are commonly encountered by the practicing neurologist. We review assessment of vision loss, diplopia, and positive visual phenomena, all of which require a thoughtful evaluation to localize disease and refine management. While m...

Nov 22nd, 2021 - Adjustable bilateral Harada-Ito procedures have been described, sometimes with asymmetric adjustment used to correct vertical misalignment when coexisting with torsional strabismus. We investigated the causes of significant postoperative torsional...

Nov 22nd, 2021 - Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a severe form of stiff-person spectrum disorder. We report a 59-year-old man who presented with progressive encephalomyelitis causing diplopia, bulbar palsy, severe dysautonomia, ...

Nov 20th, 2021 - A young woman presented to neurology with a 1 month history of progressive diplopia on lateral gaze and a 1 week history of headaches. On examination she was found to have complex ophthalmoparesis with binocular horizontal diplopia, failure of abd...

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Visual symptoms from NFPAs are common and include visual field defects, loss of central vision, and motility problems resulting in diplopia. To create evidence-based...

Oct 19th, 2021 - Orbital fracture, which accounts for 10-25% of facial fractures, is one of the most difficult facial fractures to treat. The complex bone anatomy and the proximity of adjacent vital structures make reconstruction of these fractures challenging. In...

Oct 14th, 2021 - The Study Purpose is to evaluate the efficacy and safety of a novel binocular eye-tracking-based passive home treatment system delivering personalized amblyopia therapy. Methods: Real-time foveal area blur was induced on the dominant eye of 20 par...

Sep 10th, 2021 - The goal of this study is to assess the impact (objective response) of first-line chemotherapy in infiltrative non-enhancing adult brainstem gliomas that are progressing in an infiltrative and non-threatening way. Upon progression, (radiotherapy) ...

Sep 1st, 2021 - Superior oblique palsy is one of the most common causes of vertical ocular muscle palsy. It may be congenital or acquired with over-elevation of the affected eye in primary position that increases in contralateral gaze and with ipsilateral head ti...

Jul 27th, 2021 - Epiretinal membrane (ERM) is a pathological phenomenon that leads to visual loss, visual distortions, central scotoma, and diplopia. No medical treatment is yet available. ERM surgery requires separation of normal retina and epiretinal membrane. A...

Jun 1st, 2021 - Botulinum toxin is said to be the most lethal substance known. Inhaling just 1-3 nanograms of toxin per kilogram of body mass constitutes a lethal dose.  Now the Centers for Disease Control and Prevention (CDC) has published the first comprehensiv...

May 31st, 2021 - Ocular signs and symptoms of thyroid eye disease (TED) often persist beyond the active phase of the condition, with many patients continuing to experience mental health issues and diminished quality of life, new research suggests. The autoimmune c...

Apr 23rd, 2021 - NEW YORK (Reuters Health) - Pooled clinical-trial data show that teprotumumab improves eye bulging and double vision in patients with active thyroid eye disease, with most patients having long-lasting responses. The data clearly show that teprotum...

Oct 1st, 2020 - (Reuters Health) - While ophthalmic adverse events are rare with immune checkpoint inhibitors these side effects may be more common than previously thought, a recent study suggests. Researchers examined data on 996 patients who took immune checkpo...

Oct 1st, 2020 - (Reuters Health) - While ophthalmic adverse events are rare with immune checkpoint inhibitors these side effects may be more common than previously thought, a recent study suggests. Researchers examined data on 996 patients who took immune checkpo...